(S)-4-Methyloxazolidine-2,5-dione is a chiral heterocyclic compound featuring an oxazolidinedione core structure. It serves as a versatile and valuable chiral building block in organic synthesis, particularly in the pharmaceutical industry. Its primary application is as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). The compound's structure allows for the introduction of the (S)-configuration into target molecules. A prominent example is its use in the synthesis of (S)-Dapoxetine, a short-acting selective serotonin reuptake inhibitor (SSRI) used to treat premature ejaculation. The oxazolidinedione ring can be strategically opened or further functionalized to construct complex molecular architectures. This compound is a specialty chemical of high purity, typically supplied for research and development purposes. Its utility underscores the importance of chiral heterocyclic intermediates in modern asymmetric synthesis for drug discovery and development.